Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: WWS who wrote (169)	1/10/1999 8:46:00 PM
From: Miljenko Zuanic	Respond to of 805

Bill, glad to hear that she is doing great. Hope and wish her long and healthy life. My concern in regards the placebo group is that pts have to go through invasive procedure which is not that simple like taking pills. You are right that IRB have addressed this with more concerns than I can. Still I will expect that pts requirements in this case is slower than usually. But, it does not negate protocol or trials itself. Just small ethical thought which cross my mind. Congratulation on VNRX pick. Hope that CTII can do as well. Anyway, next fey years will be very interesting for steam cells research and development of the appropriate therapy based on this technology. I am looking forward to hear your comments. Miljenko